McCarter & English, LLP | Contents of this website may contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.
8.30.2021
A Delaware federal jury found that European genetic testing company Qiagen willfully infringed a pair of patents owned by McCarter client ArcherDX, a biotech company, and Massachusetts General Hospital, awarding royalties and lost profits totaling about $4.7 million. The jury returned its verdict on the fifth day of trial, rejecting Qiagen’s argument that the patents were invalid. Law360 covered the win.
The McCarter & English, LLP website is for informational purposes only. We do not provide legal advice on this website. We can provide legal advice only to our clients in specific inquiries that they address to us. If you are interested in becoming a client, please contact us, but do not send any information about your specific legal question. We cannot serve as your lawyers until we establish an attorney-client relationship, which can occur only after we follow procedures within our firm and after we agree to the terms of the representation.
Accept Cancel